[Prostate cancer in the era of precision medicine: a new horizon]

Tu Nguyen-Ngoc1, Dominik Berthold1, Clément Normand1

  • 1Service d'oncologie médicale, Département d'oncologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Insights

Precision medicine is revolutionizing prostate cancer treatment by personalizing care to individual patients and their tumors. Targeted therapies are now improving survival rates for this common cancer.

Area of Science:

  • Oncology
  • Genomics
  • Personalized Medicine

Context:

  • Prostate cancer management traditionally relies on standardized treatment protocols.
  • Increasing understanding of tumor heterogeneity necessitates tailored therapeutic strategies.
  • Advancements in molecular diagnostics enable precise patient stratification.

Purpose:

  • To review recent advancements in targeted therapies for prostate cancer.
  • To highlight the role of precision medicine in optimizing treatment outcomes.
  • To discuss how personalized approaches are transforming prostate cancer care.

Summary:

  • Precision medicine tailors treatments to individual patient and tumor characteristics.
  • Targeted therapies offer a more personalized approach to prostate cancer management.
  • Recent innovations in targeted therapies have significantly impacted patient survival.

Impact:

  • Improved patient survival rates in prostate cancer.
  • Reduced side effects through targeted treatment selection.
  • Shift towards personalized and effective cancer care strategies.